Objective: Pulse oximetry screening of asymptomatic newborns is suggested as a life-saving procedure for the timely detection of critical congenital heart disease (CHD) in asymptomatic newborns. We evaluated this screening and report cases that demonstrate problems with screening in a non-research setting.
Introduction
The American Heart Association (AHA) and the American Academy of Pediatrics recently published a scientific statement on the role of pulse oximetry in examining newborns for congenital heart disease (CHD). 1 In a summary they state 'additional studies in larger populations and across a broad range of newborn delivery systems are needed to determine whether this practice should become the standard of care in the routine assessment of the neonate. ' The results this large recently completed public health screening of newborns by pulse oximetry will add to the overall discussion of this important issue.
The estimated incidence of CHD is 170 in 100 000 live births, and 60 in 100 000 infants have ductal-dependent left-sided obstructive lesions with the potential of presentation by shock or death if the diagnosis is missed before ductal closure. Diagnosis is performed by fetal ultrasound assessment and the newborn physical examination but is missed in 9 out of 100 000 births. 2, 3 Correct diagnosis in this small group of infants before discharge could prevent death or neurologic sequelae. Major studies using pulse oximetry screening in a research setting have been completed. [4] [5] [6] [7] When data from these studies is restricted to ductal-dependent left-sided obstructive lesions in asymptomatic populations, sensitivity values of 0 to 50% and false-positive rates of between 0.01 and 12% were found. The recent AHA review and meta-analysis calculated a low false-positive rate of 0.035% and an excellent positive predictive value of 47% for infants screened after 24 h of life. 1 In 2007, a region wide evaluation of pulse oximetry screening was performed in Tennessee, which will help with future planning of screening programs and clinical trials. In 2005, a member of the Tennessee state legislature proposed a bill that would mandate that all newborn infants born in Tennessee undergo pulse oximetry screening before discharge home. A Task Force on Screening Newborn Infants for Critical Congenital Heart Defects was convened in September 2005. This Tennessee task force reviewed the medical literature, as well as data obtained from the Tennessee Department of Health, and debated the merits and potential detriments of a statewide screening program. The task force concluded that there was insufficient evidence to perform routine screening with pulse oximetry in 2005 but that further study needed to be carried out. 8 To resolve the issue, in June 2007 the legislature authorized the Commissioner of Health to evaluate the effectiveness of pulse oximetry as a screening tool in one grand division of state. The state of Tennessee is traditionally and legally divided into three Grand Divisions. The separation is based on the major geographic features of the state. The Middle Tennessee division was chosen by the Secretary of Health for the pulse oximetry initiative, it is composed of 40 counties with a population of slightly over 2 million people, it has one major metropolitan area, two pediatric cardiology groups and one pediatric cardiothoracic surgery center.
Methods
The pulse oximetry screening consisted of obtaining a single postductal saturation from a foot of each newborn before discharge and no sooner than 24 h of age. The pulse oximeters were donated by Covidien, the Nellcortm n-560 (Nellcor Puritan Bennett LLC, doing business as Covidien in Boulder, Co, USA). The OxiMax Reusable sensor D-YS was used with SC-NEO sensors provided for infants less than 3 kg.
This elective evaluation was offered to the 30 institutions in Middle Tennessee that delivered newborns. The hospitals each deliver 20 to over 500 babies a month. This public health initiative was not research, and no funds were allocated for education and training beyond the initial setup of the pulse oximeter. Instructions were given during one visit to the charge nurse and available staff in each of the 23 hospitals agreeing to participate. The screening was performed by the nurses and aides in the nursery. They were instructed to obtain a single pulse oximeter reading from the foot of each newborn before discharge and not before 24 h of age. A result of 94 or above was deemed acceptable. These instructions were written and posted in the nursery. If a reading of 93 or less was obtained they were instructed to do the following:
'A persistent reading below 94 will require notification of the baby's health care provider. If a repeat evaluation demonstrates a pulse oximeter reading of less than 94, then a referral phone call may be made to the coordinating center. If deemed appropriate, the baby will then be evaluated by a pediatric cardiologist.'
De-identified saturations were entered into a web-based database, which included hospital of origin and saturation level or reason for no level if saturation was not reported.
All of the pediatric cardiologists in the region agreed to evaluate babies identified by screening. The cardiologists agreed to provide 24 h a day support for evaluation of these infants to minimize time of uncertainty for the family.
Separate from the state health initiative an IRB approved data collection was performed to determine the timing and mode of identification of all infants with critical CHD born to mothers from Middle Tennessee. Critical CHD was defined as abnormal cardiac anatomy sufficient to require surgery or medical management in the newborn period, excluded were ventricular septal defects, atrial septal defects and patent ductus arteriosus. Data was obtained from a weekly review of all infants less than one month of age with critical heart disease referred to or identified by the two cardiology groups. Excluded were infants born to mothers from outside Middle Tennessee. The records of all infants with a diagnosis of critical CHD were reviewed to determine timing and method of diagnosis and initial saturation level.
In addition, the death certificate data for the 40 counties of Middle Tennessee was reviewed by the State Birth Defects epidemiologist to ascertain whether any neonatal deaths were due to CHD.
The public health initiative that is the subject of this report was performed before the recommendations from the AHA were published, but the experience from this screening that was done in rural as well as metropolitan hospitals in a non-research setting will be helpful for public health planners. The public health initiative was reviewed by the university IRB and hospital IRB's, and the subsequent de-identified analysis of the data collected as part of the initiative was felt to be exempt and not require individual consent.
Results
Participation in the state screening was not mandatory and seven hospitals chose not to participate. The hospitals that did not participate had large delivery populations with a total of almost 20 000 (57%) births occurring in the non-participating units. The reasons for not participating were varied. Two centers discontinued their deliveries. The largest center with 7000 deliveries chose not to participate due to a concern that extra staffing would be necessary to administer the pulse oximeter screen. Two centers agreed to participate but never submitted any data. A large federal government delivery service could not determine whether participation was possible. One hospital refused to participate over concerns that the evaluation was a research project rather than a public health initiative.
In 2007, there were 34 818 babies born to mothers living in the 40 counties of Middle Tennessee. During that time period a total of 14 983 babies (43% of all births in region) were offered screening in the 23 participating hospitals. A brochure was distributed to the mothers explaining the pulse oximetry evaluation and allowing the mother to opt-out of the evaluation. The screening was not mandatory and if physicians, nurses or parents elected to not perform the screen, the baby was noted as having no result. There were 419 babies (2.8%) with no saturation result due to: screening not done (368); not successful (35); or parents opting out (16). One hundred and thirteen (1%) infants had an abnormal screen reported. Of the 113 infants, 3 were sent for cardiology evaluation. None of the three had CHD. The other 110 infants who failed the initial screen were not sent for further evaluation. One baby with hypoplastic left heart failed the screen (Case A). This infant was not sent for further evaluation and was not diagnosed until ductal closure at day 8 of life; therefore, no babies were diagnosed as having CHD solely on the basis of the screen (Figure 1) .
In this evaluation, if a level of 94 as suggested by many authors had been targeted 1,9 instead of 93, to define the need for
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Equipment and cost
The equipment worked well and through the entire yearlong evaluation only one non-disposable probe needed to be replaced. The reusable pulse oximeter probes made the cost of individual screening, ($0.07) per screen based on 2000 screenings per probe. The reusable probes make the screening very fast, taking 2 min or less per infant. The screening was safe, and there were no injuries or infections of any type. The probes were cleaned between babies using alcohol. Screening was successful in 99.8% of the babies in whom it was attempted. No unscreened baby presented with CHD. An important factor that must be included is the cost of evaluating the infants with abnormal screens. In our region, the providers chose to send three of the infants who had low saturations for further evaluation.
Case reports
Two screened infants are of interest and illustrate the problems associated with screening a large population in centers without readily available pediatric echocardiology support:
Baby A had a normal newborn course, the baby was screened and found to have a saturation of 93. The care provider reexamined the infant, the baby was discharged. At 8 days of age, the baby presented with respiratory distress, pallor and acidosis and was found to have hypoplastic left heart. The baby did well after surgery. Despite being detected by the screen, this baby was not referred for echocardiogram and not diagnosed. It was beyond the scope of this evaluation to determine why the baby did not get referred for echocardiogram. Referral decisions were left to the discretion of the provider.
Baby B had a screen performed with saturation of 89. A screening echocardiogram was performed by a non-pediatric echocardiologist at the local hospital. The baby was felt to have ductal shunting and a coarctation of the aorta. A transport team was notified and prostin started. The baby became apneic and required intubation and ventilation. Baby B was transported to the regional center where echocardiogram was unable to determine the presence of coarctation in the face of a ductus arteriousus. Baby was observed until ductal closure when a final echocardiogram demonstrated that the baby had normal anatomy. Total hospitalization was 4 days with a large hospital bill and parental anxiety. This case demonstrates that echocardiogram is not infallible.
Babies with CHD
CHD was defined for this study as any obstructive or cyanotic lesion severe enough to need medical or surgical management in the first Figure 1 Results of the region wide screening initiative.
Evaluation of pulse oximetry screening in Middle Tennessee W Walsh month of life. Excluded were patent ductus arteriosus, ventricular septal defects and atrial septal defect lesions. There were 44 infants with CHD born in the region to mothers from that region (1.2/1000) during the study. Forty-three of 44 infants were known before discharge. A review of the state death records was carried out and no cases of CHD presenting as death occurred. Twenty-nine of the 44 infants were identified prenatally by the obstetrician (66%), 14 were identified due to symptoms before discharge (32%) and one was discharged home without diagnosis (Baby A).
Ten of the 44 infants (23%, confidence interval 10 to 35%) with critical CHD had saturation levels which were greater than 93 at diagnosis, including one baby with a 99 and another with a saturation of 100%. Thus, if saturation monitoring were the sole criterion for evaluation, a significant number of babies with CHD would be missed. None of the babies with CHD had a saturation of exactly 94. It must be noted that the timing of the saturation measurement was not standard for the babies with CHD and the value reported is after the diagnosis (Table 1) .
Discussion
The standard method of detecting critical CHD is a combination of the antenatal sonographic evaluation of the fetus and a pediatric evaluation. The AHA statement on pulse oximetry screening assumes a detection rate of fetuses with critical CHD of less than 30%. However in the infants cared for in Middle Tennessee, the obstetric community did a surprisingly good job of identifying fetuses with critical CHD detecting 29 of the 44 affected fetuses before birth. The rate of detection is crucial when determining the benefits of pulse oximetry screening. We did not evaluate the efficacy of antenatal detection by size or location of delivery service; in populations with limited or no prenatal care, pulse oximetry screening should be more beneficial. The combined antenatal and postnatal approach works very well in Middle Tennessee, only 1 (2%) baby with critical CHD was diagnosed after discharge. This is less than the 25% reported by Brown et al.
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As would be expected in screening for a low incidence condition, the negative predictive value of pulse oximetry is extremely high. In our population with no cases of critical CHD in over 14 000 babies with normal saturation we had a negative predictive value of 100%. However false-negative evaluations do occur and the reported sensitivity of pulse oximetry screening is 70%. 1 The data from the critical CHD babies diagnosed by other means agree with this reported sensitivity, with 34 of the 44 (77%, confidence interval 65 to 90%) infants having a saturation under 94%.
Pulse oximetry is a simple and economical means to detect critical CHD that is missed by the routine examination. In this population, pulse oximetry detected the one baby with critical CHD missed by both antenatal OB and pediatric evaluation. The hospital cost of the false-positive baby was over $60 000, but it would not be appropriate to attempt to make national cost-benefit estimates from our data with only one patient missed and one misdiagnosed. The fallibility of echocardiography is well recognized and acknowledged when considerations of echocardiogram as the method of universal screening are performed, 11 but in the metaanalysis of the benefits of pulse oximetry screening echocardiogram is presumed to be easily accessible and accurate. 1 The fact that a case of hypoplastic left heart was discharged undiagnosed due to lack of subsequent echocardiogram evaluation is an important issue. An important difference between this evaluation and other reports is that pediatric cardiologists were only available in 2 of the 23 centers. The remainder of the hospitals had to refer a baby for evaluation. The distance from the rural hospitals to the referral center ranged from 15 to 100 miles. In an attempt to limit referral of false-positive evaluation providers were encouraged to repeat the saturation and the physical examination before referring. This secondary confirmatory screen approach to the infant with a single low saturation measurement has not been studied nor reported in any of the previous trials of pulse oximetry screening. In our region, this screening resulted in a decrease in the false-positive rate from a potential 0.7% to actual 0.02%. Unfortunately, this secondary screening was associated with the failure to diagnose the single infant (Case A) who had a true positive screen.
There will be babies without CHD who fail any screening test, thus an important part of universal screening in large populations will be the inclusion of evidence-based recommendations regarding the urgency, timing and mechanism of echocardiogram screening of infants with low saturations. Transport and referral guidelines are essential, as the majority of US hospitals do not have on-site pediatric echocardiogram capability.
A report of 27 200 infants screened at 26 h of life with an action level of 94% saturation in 26 Polish hospitals demonstrated only 13 false-positive infants and 7 true positives for a positive predictive value of 35%. This large Polish population study provides over half of the patients used in the AHA scientific statement on the use of Evaluation of pulse oximetry screening in Middle Tennessee W Walsh pulse oximetry to screen for CHD. 12 Compared with the Polish study, our evaluation had a very poor positive predictive value of less than 1%.
The high false-positive rate we saw occurred even using the lower 94% saturation as the cutoff level. The false positives may have been due to the lack of experience of the personnel performing the evaluation or even be due to inaccurate reporting as there was no on-site confirmation of the reported result. Using the 94% level might decrease the false-positive rate at the cost of sensitivity, but the Tennessee evaluation resulted in no cases of critical CHD missed by the screen. Had the 95% saturation level used in the Polish study been applied to the Tennessee population, the positive predictive value would be one true positive in 516-positive screens. It is difficult to compare studies; however, this report suggests that the use of the pulse oximetry screen in a non-research environment applied to an asymptomatic population with excellent obstetric and pediatric care cannot be recommended at this time.
Summary
A massive trial will have to be performed to determine if the hypothetical cost-effectiveness of universal pulse oximetry screening can be verified. Before such a trial is considered, it is essential to address the issues of transport and subsequent evaluation of positives raised in this paper.
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